Biomerica, Inc.
BMRA
$0.6653
$0.05839.61%
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.02M | 1.57M | 1.71M | 1.11M | 1.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.02M | 1.57M | 1.71M | 1.11M | 1.11M |
| Cost of Revenue | 1.17M | 1.24M | 1.30M | 1.08M | 991.00K |
| Gross Profit | -149.00K | 325.00K | 412.00K | 28.80K | 120.00K |
| SG&A Expenses | 1.51M | 1.52M | 1.17M | 1.21M | 1.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.02M | 3.18M | 2.95M | 2.65M | 2.76M |
| Operating Income | -2.00M | -1.61M | -1.23M | -1.55M | -1.65M |
| Income Before Tax | -1.91M | -1.50M | -1.11M | -1.78M | -1.62M |
| Income Tax Expenses | 4.00K | 8.00K | 23.00K | 13.00K | 35.00K |
| Earnings from Continuing Operations | -1.92M | -1.51M | -1.13M | -1.79M | -1.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.92M | -1.51M | -1.13M | -1.79M | -1.65M |
| EBIT | -2.00M | -1.61M | -1.23M | -1.55M | -1.65M |
| EBITDA | -1.98M | -1.59M | -1.21M | -1.53M | -1.63M |
| EPS Basic | -0.11 | -0.09 | -0.07 | -0.11 | -0.12 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.04 | -0.06 | -0.07 |
| EPS Diluted | -0.11 | -0.09 | -0.07 | -0.11 | -0.12 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.04 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 16.82M | 16.82M | 16.82M | 16.59M | 13.48M |
| Average Diluted Shares Outstanding | 16.82M | 16.82M | 16.82M | 16.59M | 13.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
